Anesthesiology

IntelliGuard Accelerates Corporate Growth with Office and Team Expansions in North America

Retrieved on: 
Wednesday, October 11, 2023
Research, Supply Chain Management, General Health, Pharmaceutical, Technology, Hospitals, Health Technology, Retail, Science, Other Technology, Other Science, Health, Multimedia, Data science, Hospital, Acquisition, Pharmacy, Healthcare Facilities Accreditation Program, Workflow, Patient safety, Growth, Anesthesiology

IntelliGuard , a fast-growing provider of medication management systems, is expanding the company’s presence in North America by adding two new offices - one in Columbus, Ohio, and one in Toronto, Canada.

Key Points: 
  • IntelliGuard , a fast-growing provider of medication management systems, is expanding the company’s presence in North America by adding two new offices - one in Columbus, Ohio, and one in Toronto, Canada.
  • IntelliGuard is also investing significantly in personnel, increasing its sales team and field-based workforce, as well as investing in new technology by acquiring supply chain management company Supplymind Healthcare Technologies.
  • View the full release here: https://www.businesswire.com/news/home/20231011516338/en/
    IntelliGuard Columbus Ohio Office (Photo: Business Wire)
    These strategic moves position IntelliGuard to more effectively engage and support local and regional healthcare organizations throughout North America with the shared goal of advancing patient safety.
  • “IntelliGuard’s expansion in North America, the growth of our sales team, and the recent acquisition of Supplymind propel IntelliGuard forward as a leader in cutting-edge medication and supply chain management solutions.

Pieper Veterinary Partners with Portland Veterinary Emergency and Specialty Care Hospital in Portland Maine

Retrieved on: 
Monday, October 16, 2023
Ophthalmology, Partnership, Hospital, Internal medicine, Cardiology, Neurology, Professional, DVM, Patient, Anesthesiology, Veterinary medicine, Anciens Etablissements Pieper

MIDDLETOWN, Conn., Oct. 16, 2023 /PRNewswire/ -- Pieper Veterinary, a Connecticut-based family of primary, specialty, and emergency care veterinary hospitals, is excited to announce they have partnered with Portland Veterinary Emergency and Specialty Care (PVESC) in Portland, Maine.

Key Points: 
  • MIDDLETOWN, Conn., Oct. 16, 2023 /PRNewswire/ -- Pieper Veterinary, a Connecticut-based family of primary, specialty, and emergency care veterinary hospitals, is excited to announce they have partnered with Portland Veterinary Emergency and Specialty Care (PVESC) in Portland, Maine.
  • Pieper Veterinary announces partnership with Portland Veterinary Emergency and Specialty Care in Portland, Maine.
  • Started in 1988, Portland Veterinary Emergency and Specialty Care was unified as an ER and Specialty Hospital in 2019 by surgeon and founder Marta Agrodnia, DVM, DACVS-SA.
  • PVESC's specialty departments include anesthesiology, emergency & critical care, cardiology, oncology, internal medicine, surgery, ophthalmology, and neurology.

Masimo Receives EU MDR CE Mark for LiDCO® Module for Hemodynamic Monitoring

Retrieved on: 
Monday, October 9, 2023
Medical Devices, Health, Hospitals, Surgery, Health Technology, Cardiology, Southampton General Hospital, Multimedia, Nursing care plan, Hospital, Consultant, Doctor of Philosophy, MASI, BIC, Intelligence, Brain, Anesthesiology, MD, Stroke volume, Mortality, Root, Intensive care medicine, ERAS, FDA, Physiology, CE, Cardiac output, Blood pressure, ICU, OR, Patient, Medical device, Nursing, Anesthesia, Masimo, Neuroscience

The LiDCO BIC module is designed to connect to multi-patient monitoring platforms, like the Masimo Root® Patient Monitoring and Connectivity Hub, to provide advanced hemodynamic monitoring.

Key Points: 
  • The LiDCO BIC module is designed to connect to multi-patient monitoring platforms, like the Masimo Root® Patient Monitoring and Connectivity Hub, to provide advanced hemodynamic monitoring.
  • With this solution, clinicians can easily add LiDCO hemodynamic monitoring – with its one-of-a-kind versatile PulseCO® algorithm – to their Root patient monitoring hubs.
  • For the first time, there is now a solution that can enable hemodynamic monitoring alongside other supported parameters without having a dedicated hemodynamic monitoring box.
  • Combining Masimo rainbow® Pulse CO-Oximetry and LiDCO hemodynamic monitoring brings the potential for significant new insights into patient status.

GE HealthCare Launches Enhanced Venue Family Point-of-Care Ultrasound Systems Featuring AI-Driven Caption Guidance

Retrieved on: 
Friday, October 6, 2023
Cardiology, Software, Radiology, Health, Artificial Intelligence, Medical Devices, Health Technology, Technology, Diagnosis, Triage, American Society of Anesthesiologists, Acquisition, ACEP, American College, AI, Heart failure, Society, Death, Heart, Emergency, Artificial intelligence, Ultrasound, GE, Caption, ASA, GE HealthCare, Fellow of the American College of Emergency Physicians, Chief digital officer, Digital Solutions, Patient, Anesthesiology, Medical imaging

GE HealthCare (Nasdaq: GEHC) today announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images.

Key Points: 
  • GE HealthCare (Nasdaq: GEHC) today announced its Venue Family point-of-care ultrasound systems will now feature Caption Guidance, artificial intelligence (AI)-driven technology that provides real-time guidance to users for capturing diagnostic-quality cardiac images.
  • The Venue Family is the first among GE HealthCare ultrasound products to incorporate this scan guidance technology following the company’s acquisition of Caption Health earlier this year.
  • “Venue Family ultrasound systems support clinical decision-making at the point of care, including the emergency department, offering simple, fast and precise solutions.
  • GE HealthCare will debut the Venue Family ultrasound systems featuring Caption Guidance, and the Verisound brand, at the American College of Emergency Physicians (ACEP) Scientific Assembly taking place October 9-12 in Philadelphia.

Alentis Therapeutics Appoints Lung Experts Professors Tony Mok and Steven Nathan to its Scientific Advisory Board

Retrieved on: 
Thursday, October 5, 2023
Oncology, Health, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Aurora, Histology, Chinese University of Hong Kong, Multimedia, Science, Lung cancer, Biomarker, Chinese, University, Cedars-Sinai Medical Center, CLDN1, Abstract, Lung transplantation, The New England Journal of Medicine, AACR, Anesthesiology, Clinical Oncology, Clarivate, Long Island Jewish Medical Center, Book, Coronavirus Scientific Advisory Board, IPF, Respiratory therapist, University of the Witwatersrand School of Chemical and Metallurgical Engineering, Food and Drug Administration, Lung, US Food Sovereignty Alliance, Medical director, Patient, Idiopathic pulmonary fibrosis, AstraZeneca, ESMO, Therapy, Article, Publication, Long Island, ASCO, Pulmonary hypertension, CSCO, Research, Inova Fairfax Hospital, Pharmaceutical industry, Medical device, Vaccine

Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today the appointment of Tony Mok, Professor of Clinical Oncology at the Chinese University of Hong Kong and Steven Nathan, Professor at the University of Virginia as members of its Scientific Advisory Board.

Key Points: 
  • Alentis Therapeutics (“Alentis”), the clinical-stage biotechnology company developing treatments for Claudin-1 positive (CLDN1+) tumors and organ fibrosis, announced today the appointment of Tony Mok, Professor of Clinical Oncology at the Chinese University of Hong Kong and Steven Nathan, Professor at the University of Virginia as members of its Scientific Advisory Board.
  • View the full release here: https://www.businesswire.com/news/home/20231005193827/en/
    Lung experts Prof. Steven Nathan and Prof. Tony Mok join Alentis Therapeutics' Scientific Advisory Board.
  • (Photo: Alentis Therapeutics)
    “Tony and Steven have exceptional expertise in lung cancer and lung fibrosis, respectively, which will be of great value to our Scientific Advisory Board,” said Dr. Luigi Manenti, Chief Medical Officer of Alentis.
  • Prof. Steven Nathan is the Medical Director of the Advanced Lung Disease and Lung Transplant Program at Inova Fairfax Hospital and is a Professor at the University of Virginia.

The Inner Circle Acknowledges, Dr. Timothy L. Smith as an Inner Circle Platinum Member for his contributions to the field of Nurse Anesthesiology

Retrieved on: 
Wednesday, October 11, 2023
Capital, Multimedia, Knowledge, Physiology, Doctor of Philosophy, Student, Liberal arts education, Anesthesiology, Southern Baptist Theological Seminary, Harvard Extension School, University of Mobile, University, Health, Business administration, Shaker, Education, American Association of Nurse Anesthesiology, Harley, Publication, Theology, Potchefstroom University for Christian Higher Education, Life, Inner circle, Research, Dentistry, Nursing, Anesthesia

GERMANTOWN, Tenn., Oct. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Timothy L. Smith is acknowledged as an Inner Circle Platinum Member for his contributions to the field of Nurse Anesthesiology.

Key Points: 
  • GERMANTOWN, Tenn., Oct. 11, 2023 /PRNewswire/ -- Prominently featured in The Inner Circle, Dr. Timothy L. Smith is acknowledged as an Inner Circle Platinum Member for his contributions to the field of Nurse Anesthesiology.
  • The doctor's illustrious career spans more than 30 years as a certified registered nurse anesthetist.
  • Dr. Smith has more than 25 years invested in academia, setting the foundation for the significant contributions he has made to healthcare education and research.
  • Aside from his professional pursuits, Dr. Smith notes that he finds exhilaration and a sense of freedom riding Harley motorcycles.

Akita Biosciences Launches to Pioneer Novel Intranasal Therapies

Retrieved on: 
Tuesday, October 10, 2023
IID, Health, Hospital, Distinguishing, Bacteria, Nasal cavity, Therapy, GRAS, FDA, Cone Health Women's Hospital, Risk, Virus, Escherichia coli, Brigham and Women's Hospital, Harvard Medical School, Assistant, Nose, SARS-CoV-2, RSV, Research, Infection, Atmosphere, Pharmaceutical industry, Vaccine, Anesthesiology, Brigham, COLUMBUS, Profi

BOSTON and COLUMBUS, Ohio, Oct. 10, 2023 /PRNewswire/ -- Akita Biosciences, a biotechnology company focused on consumer health, is launching today with a mission to bring novel therapies to market. The company is developing pioneering science around the importance of the nasal cavity, both as a pathway for therapeutics and as a way to defend against illness. Akita Biosciences was founded based on research conducted at Brigham and Women's Hospital in Boston.

Key Points: 
  • BOSTON and COLUMBUS, Ohio, Oct. 10, 2023 /PRNewswire/ -- Akita Biosciences , a biotechnology company focused on consumer health, is launching today with a mission to bring novel therapies to market.
  • Akita Biosciences was founded based on research conducted at Brigham and Women's Hospital in Boston.
  • Based on this research, "Akita Biosciences developed a radically simple approach that works with the natural defenses in the nose," said Alex Revelos, CEO.
  • Building on the commercial launch of Profi, Akita Biosciences expects to continue developing biomaterials to support a wide range wellness, drug delivery, and therapeutic applications.

Obesity Control Center Reaffirms Commitment to Quality Care Through Latest GHA Accreditation

Retrieved on: 
Tuesday, October 10, 2023
BEACH, Government, Education, Control center, Accreditation, Communication, Anesthesiology, Medical tourism, GHA, Patient advocacy, Safety, Travel, Interim, International, Trust, Patient safety, Nursing, Cultural competence, Bariatric surgery, PALM, Exercise, English, Risk management, Patient, Chronic care management, Hospital, Medical device

PALM BEACH GARDENS, Fla., Oct. 10, 2023 /PRNewswire/ -- Obesity Control Center has been awarded Accreditation for Medical Travel Services by Global Healthcare Accreditation (GHA) for a second term, underscoring its commitment to exceptional care for traveling patients.

Key Points: 
  • PALM BEACH GARDENS, Fla., Oct. 10, 2023 /PRNewswire/ -- Obesity Control Center has been awarded Accreditation for Medical Travel Services by Global Healthcare Accreditation (GHA) for a second term, underscoring its commitment to exceptional care for traveling patients.
  • Obesity Control Center was first accredited by GHA, the global leader in medical travel accreditation, in 2019.
  • "We congratulate Obesity Control Center on attaining GHA Accreditation for a second term and for their dedication to excellence in medical travel," said Ms. Renée-Marie Stephano, Interim Chief Executive Officer of Global Healthcare Accreditation."
  • With Obesity Control Center renewing its GHA Accreditation, the organization continues as an esteemed member of GHA's internationally recognized provider network .

Solomon Partners to Expand Healthcare Group with Hiring of Karan Garg (KG) and Brad Hildebrand

Retrieved on: 
Monday, October 2, 2023
Avista Capital Partners, Health care, Houlihan, Solomon Partners, Houlihan Lokey, Acıbadem Healthcare Group, Practice management, Brad, GI, Anesthesiology, Dentistry, Pharmaceutical industry, Nursing

NEW YORK and CHICAGO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Solomon Partners , a leading financial advisory firm, announced that it has appointed Karan Garg (KG) as Head of Healthcare Services in the firm’s Healthcare Group and has also hired Brad Hildebrand as a Managing Director focused on Healthcare Services.

Key Points: 
  • NEW YORK and CHICAGO, Oct. 02, 2023 (GLOBE NEWSWIRE) -- Solomon Partners , a leading financial advisory firm, announced that it has appointed Karan Garg (KG) as Head of Healthcare Services in the firm’s Healthcare Group and has also hired Brad Hildebrand as a Managing Director focused on Healthcare Services.
  • Mr. Hildebrand also has deep experience advising clients in multisite retail healthcare and physician practice management among a variety of other subsectors within healthcare services.
  • Prior to joining Solomon Partners, Mr. Garg was a Managing Director and a senior member in Houlihan Lokey’s Healthcare group where he spent over 15 years expanding the firm’s healthcare services practice.
  • Mr. Hildebrand also worked at Houlihan Lokey in the Healthcare Group, and he joins Solomon from Bridgeway Capital Partners where he led the firm’s efforts in the Healthcare Services vertical.

Revelation Biosciences Inc. Announces Appointment of Lakhmir Chawla, M.D. to Board of Directors

Retrieved on: 
Monday, October 2, 2023
Biotechnology, Pharmaceutical, Health, Hospice and palliative medicine, Drug development, Therapy, Chronic kidney disease, Anesthesiology, Critical Care Medicine (journal), Nephrology, Kidney, Shock, Hypertension, American Board of Internal Medicine, Biomarker, AKI, Acute kidney injury, Retirement, Patient, Division, Labelle, George Washington University, Disease, Pharmaceutical industry, Medicine

to the Company’s Board of Directors (Board).

Key Points: 
  • to the Company’s Board of Directors (Board).
  • “We are excited to welcome Dr. Chawla as an independent director to our Board,” said James Rolke, Chief Executive Officer of Revelation.
  • “Dr.
  • Dr. Chawla joins the Revelation Board on the recent retirement from the Board of Curt LaBelle M.D.